Diabetes PubMed

  • Increase font size
  • Default font size
  • Decrease font size
Home Complications Long Term Eyes Strategy for treatment of diabetic retinopathy

Strategy for treatment of diabetic retinopathy

Nippon Ganka Gakkai Zasshi. 2010 Mar;114(3):202-15; discussion 216.

[Article in Japanese]

Hori S.

Department of Ophthalmology, Tokyo Women's Medical University, Japan.

This paper conducts an analysis and discussion of the pathogenesis and treatment strategies for diabetic retinopathy, a major cause of blindness. Histological examination of experimental and biopsied material found that the pericyte necrosis and basement membrane thickening were responsible for sclerosis of retinal microvessels. The macrophages were noted in the pathogenesis of retinopathy. The cytokines of intraocular fluid were analyzed, and the vascular endothelial growth factor and intercellular adhesion molecule-1 were found to be closely related to retinopathy and macular edema. These findings suggest that the inflammation lead to the complex pathology of retinopathy. Anti-inflammatory drugs need to be included in the therapeutic strategy. The Diabetic Eye Notebook is an important source of information for patients who were lost to followup.

PMID: 20387536

 

Bookmark and Share

Popular Diabetes PubMed Citations

Newsflash

Millions unite for diabetes awareness on World Diabetes Day 2010
Starting today, people from all corners of the world are uniting together for three days of celebration to put diabetes firmly in the public spotlight. World Diabetes Day is the best opportunity there is to draw attention to the silent killer that is diabetes.
 
Bristol-Myers Squibb Foundation Launches $100 Million Initiative
The Bristol-Myers Squibb Foundation announced Together on Diabetes®: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office - in their homes and communities - and for the course of their disease.
 
New global survey reveals more than one in three patients fail to take insulin as prescribed
More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77% of physicians estimate that in reality this number could be as high as six doses*, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPPTM) survey, released today by Novo Nordisk.
 

Facebook Page Twitter Subscribe to Latest Diabetes PubMed facts... by Email RSS

Subscribe

Get Diabetes PubMed facts delivered by email. Enter your email address:


Delivered by FeedBurner

Who's Online

We have 7 guests online

Sponsored Links

PharmaNews.eu
PharmaNews.eu - the dynamic European pharmaceutical news engine.
www.pharmanews.eu

Advertise here